相关实验视频

Updated: Jul 2, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

消除麻疹的进展 - 世界卫生组织东地中海地区,2019-2022年

Nasrin Musa, Amany Ghoniem, Christopher H Hsu

MMWR. Morbidity and mortality weekly report

|February 22, 2024

概括

东地中海地区 (EMR) 的麻疹消除工作因COVID-19大流行而面临挫折,麻疹发病率增加和监测减少. 实现消除需要加强免疫计划和疾病监测.

科学领域:

公共卫生公共卫生
流行病学流行病学
疫苗学疫苗学疫苗学

背景情况:

世界卫生组织东地中海地区 (EMR) 承诺到2020年消除麻疹.
尽管取得了进展,但大多数EMR国家尚未消除麻疹.
本报告详细介绍了EMR麻疹消除在2019-2022年的进展情况.

研究的目的:

在EMR中更新麻疹消除的状态.
分析疫苗接种覆盖率和麻疹发病率趋势.
确定挑战,并推战略,以实现消除麻疹.

主要方法:

对区域含麻疹疫苗 (MCV) 覆盖率估计的分析.
审查国家和地方补充免疫活动.
评估报告的确诊麻疹发病率和监测指标.

主要成果:

在2019-2022年期间,估计的MCV覆盖率仍未达到最佳水平 (MCV1: 82%-83%,MCV2: 76%-78%).
麻疹发病率在2020年下降,但在2022年升68%,达到每百万病例的50.0例.
监测指标在50%的EMR国家下降;四个国家实现了消除.

结论:

"COVID-19"大流行严重影响了免疫服务和监测,阻碍了麻疹的消除.
免疫缺口和2022年麻疹发病率的增加凸显了当前的挑战.
持续努力的疫苗接种覆盖率和高质量的监测对于在EMR消除麻疹至关重要.

更多相关视频

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Remote Laboratory Management: Respiratory Virus Diagnostics

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

相关概念视频

Vaccinations

Vaccinations

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...